Akoya Biosciences, Inc. Non-Employee Director Compensation Policy (Adopted May 16, 2024)
Akoya Biosciences, Inc. has established a compensation policy for its non-employee directors, effective May 16, 2024. Under this policy, non-employee directors receive annual cash retainers based on their board and committee roles, with additional amounts for serving as chair or as a committee member. Upon joining the board, non-employee directors are granted stock options valued at $255,000, vesting over three years. After each annual stockholder meeting, they receive additional stock options valued at $170,000, subject to a 50,000 option cap, vesting by the next annual meeting or after one year.
Exhibit 10.1
AKOYA BIOSCIENCES, INC.
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Adopted May 16, 2024
Position |
| Annual Retainer |
| |
Board Membership | | $ | 40,000 | |
Non-Executive Chair of the Board | | $ | 40,000 | |
Chair of Audit Committee | | $ | 20,000 | |
Chair of the Compensation Committee | | $ | 15,000 | |
Chair of the Innovation and Technology Committee | | $ | 15,000 | |
Chair of the Corporate Governance and Nominating Committee | | $ | 10,000 | |
Audit Committee Members other than Chair | | $ | 10,000 | |
Compensation Committee Members other than Chair | | $ | 7,500 | |
Innovation and Technology Committee Members other than Chair | | $ | 7,500 | |
Nominating and Corporate Governance Committee Members other than Chair | | $ | 5,000 | |
Upon joining the Board, non-employee directors will receive an initial grant of options to purchase shares of our common stock with a value of $255,000. These stock option awards have an exercise price per share equal to the fair market value on the grant date with such awards vesting in three equal annual installments.
Following each annual meeting of the stockholders, non-employee directors will receive a grant of options to purchase shares of our common stock with a value of $170,000; provided that the number of stock options a non-employee director may receive in any such annual grant shall not exceed 50,000. These stock option awards have an exercise price per share equal to the fair market value on the grant date with such awards shall vest on the earlier of the anniversary of the grant date or the next annual meeting of stockholders.
